NPPA fixed the retail price of the Telmisartan I.P. 40 mg + Chlorthalidone IP 6.25 mg + Metoprolol Succinate I.P. 47.5 mg eq. to Metoprolol Tartrate 50 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer)

Mar 18, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 17, 2025, fixed the retail price of the Telmisartan I.P. 40 mg + Chlorthalidone IP 6.25 mg + Metoprolol Succinate I.P. 47.5 mg eq. to Metoprolol Tartrate 50 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer).

The following have been stated:

• The retail price of the Each film coated bilayered tablet contains: Telmisartan I.P. 40 mg + Chlorthalidone IP 6.25 mg + Metoprolol Succinate I.P. 47.5 mg eq. to Metoprolol Tartrate 50 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer) will be Rs. 10.73/-.

• Sum of MAT value considered for price calculation (in Lakhs) - 991.01

• Sum of PTR per unit considered for price calculation - 64.76


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT